Is CBT a good stock to buy? We came across a bearish thesis on Cabot Corporation on Valueinvestorsclub.com by celtsfan86. In this article, we will summarize the bears’ thesis on CBT. Cabot Corporation’s share was trading at $86.35 as of July 2nd. CBT’s trailing and forward P/E were 16.36 and 10.62 respectively according to Yahoo Finance.
cybrain/Shutterstock.com
Cabot Corporation operates as a specialty chemicals and performance materials company. CBT is presented as a global specialty chemicals company whose Reinforcement Materials segment (~65% of revenue and ~68% of EBITDA) is entering a structurally weaker phase driven by both demand destruction and intensifying low-cost competition.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
The thesis argues that FY26 EPS of $6.00–$6.50 represents not a trough but a temporary plateau before further erosion, as carbon black pricing in Western markets resets down 7–9% in CY26 while volumes remain pressured by declining domestic tire production in North America and Europe.
Asian tire imports have materially displaced Western production, reducing utilization below 80% in the Americas and weakening Cabot’s pricing power, while Indian carbon black producers are rapidly gaining share in Europe and the US following tariff reductions to ~8–9%, with further downside risk as EU trade barriers potentially fall further.
The Reinforcement Materials margin structure is argued to be at risk of falling below its pre-Russia baseline of ~19% EBITDA, as prior support from Russian supply removal has fully unwound and new structural headwinds from India-based capacity expansion, weaker tire demand, and sustainability-driven substitution in non-tire rubber applications intensify. Even as Cabot rationalizes capacity and pursues cost savings, these levers are seen as insufficient against accelerating competitive pressure and sustained volume declines across multiple quarters.
The Performance Chemicals segment offers partial offset through battery materials growth, including a 39% YoY increase in conductive carbon additives and a PowerCo deal, but its ~$34 million EBITDA contribution is too small relative to Reinforcement Materials’ cyclical decline. Broader PC volumes remain weak outside batteries, limiting diversification benefits.
While bulls point to strategic assets, pricing actions, and potential catalysts such as asset monetization or geopolitical normalization, the bearish view emphasizes that structural demand erosion and import competition outweigh these supports. The stock’s prior recovery is viewed as driven by short-term announcements rather than durable earnings inflection, leaving valuation vulnerable if margins revert toward or below historical lows.
Previously, we covered a bullish thesis on Eastman Chemical Company (EMN) by Necessary-Damage5658 in November 2024, which highlighted export control tailwinds and compliant chemical demand strength. EMN’s stock price has depreciated by approximately 31.87% since our coverage. celtsfan86 shares a contrarian view but emphasizes structurally weaker dynamics in Cabot Corporation (CBT) driven by import-led carbon black margin compression.
Cabot Corporation is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 25 hedge fund portfolios held CBT at the end of the first quarter which was 23 in the previous quarter. While we acknowledge the risk and potential of CBT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CBT and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
